SiBone (SIBN) Competitors $15.21 -0.12 (-0.78%) Closing price 10/8/2025 04:00 PM EasternExtended Trading$15.21 +0.00 (+0.03%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock SIBN vs. INSP, EYE, PRCT, AORT, LMAT, LQDA, ENOV, CDRE, NVCR, and CNMDShould you be buying SiBone stock or one of its competitors? The main competitors of SiBone include Inspire Medical Systems (INSP), National Vision (EYE), PROCEPT BioRobotics (PRCT), Artivion (AORT), LeMaitre Vascular (LMAT), Liquidia Technologies (LQDA), Enovis (ENOV), Cadre (CDRE), NovoCure (NVCR), and CONMED (CNMD). These companies are all part of the "medical equipment" industry. SiBone vs. Its Competitors Inspire Medical Systems National Vision PROCEPT BioRobotics Artivion LeMaitre Vascular Liquidia Technologies Enovis Cadre NovoCure CONMED Inspire Medical Systems (NYSE:INSP) and SiBone (NASDAQ:SIBN) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, risk, valuation, analyst recommendations, media sentiment and institutional ownership. Is INSP or SIBN more profitable? Inspire Medical Systems has a net margin of 6.17% compared to SiBone's net margin of -12.83%. Inspire Medical Systems' return on equity of 10.38% beat SiBone's return on equity.Company Net Margins Return on Equity Return on Assets Inspire Medical Systems6.17% 10.38% 8.93% SiBone -12.83%-14.20%-10.38% Do analysts prefer INSP or SIBN? Inspire Medical Systems presently has a consensus target price of $152.64, indicating a potential upside of 94.45%. SiBone has a consensus target price of $23.67, indicating a potential upside of 55.60%. Given Inspire Medical Systems' higher possible upside, equities analysts clearly believe Inspire Medical Systems is more favorable than SiBone.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inspire Medical Systems 1 Sell rating(s) 7 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.40SiBone 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 Does the media refer more to INSP or SIBN? In the previous week, SiBone had 3 more articles in the media than Inspire Medical Systems. MarketBeat recorded 10 mentions for SiBone and 7 mentions for Inspire Medical Systems. SiBone's average media sentiment score of 0.44 beat Inspire Medical Systems' score of 0.26 indicating that SiBone is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Inspire Medical Systems 3 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SiBone 4 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has higher earnings & valuation, INSP or SIBN? Inspire Medical Systems has higher revenue and earnings than SiBone. SiBone is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInspire Medical Systems$802.80M2.89$53.51M$1.7345.38SiBone$167.18M3.92-$30.91M-$0.56-27.16 Which has more volatility & risk, INSP or SIBN? Inspire Medical Systems has a beta of 1.16, indicating that its stock price is 16% more volatile than the S&P 500. Comparatively, SiBone has a beta of 0.83, indicating that its stock price is 17% less volatile than the S&P 500. Do institutionals and insiders believe in INSP or SIBN? 94.9% of Inspire Medical Systems shares are held by institutional investors. Comparatively, 98.1% of SiBone shares are held by institutional investors. 4.1% of Inspire Medical Systems shares are held by insiders. Comparatively, 4.0% of SiBone shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. SummaryInspire Medical Systems beats SiBone on 11 of the 16 factors compared between the two stocks. Get SiBone News Delivered to You Automatically Sign up to receive the latest news and ratings for SIBN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SIBN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SIBN vs. The Competition Export to ExcelMetricSiBoneMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$661.35M$6.99B$6.10B$10.55BDividend YieldN/A1.16%5.69%4.75%P/E Ratio-27.1627.6685.6027.60Price / Sales3.92195.36538.21205.12Price / CashN/A21.7337.9261.55Price / Book3.825.4513.246.76Net Income-$30.91M$178.04M$3.30B$275.88M7 Day Performance6.29%4.21%4.35%2.81%1 Month Performance-5.17%12.27%9.51%9.24%1 Year Performance18.46%34.25%88.04%35.42% SiBone Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SIBNSiBone3.969 of 5 stars$15.21-0.8%$23.67+55.6%+13.1%$661.35M$167.18M-27.16350Positive NewsAnalyst ForecastINSPInspire Medical Systems4.8177 of 5 stars$75.46-2.3%$154.43+104.6%-62.0%$2.28B$802.80M43.621,246Analyst ForecastEYENational Vision2.2798 of 5 stars$29.24+2.5%$24.73-15.4%+170.0%$2.26B$1.82B-162.4413,411Positive NewsAnalyst ForecastPRCTPROCEPT BioRobotics2.9278 of 5 stars$36.49-0.5%$70.00+91.8%-53.0%$2.04B$274.95M-23.54430Analyst ForecastAORTArtivion2.9985 of 5 stars$42.03+2.4%$43.13+2.6%+59.6%$1.94B$388.54M-100.061,600Analyst ForecastLMATLeMaitre Vascular3.8648 of 5 stars$85.45+1.5%$97.60+14.2%-2.6%$1.91B$234.64M41.48490Analyst ForecastLQDALiquidia Technologies3.4157 of 5 stars$22.80+4.6%$32.11+40.8%+118.5%$1.88B$14M-13.4150Analyst ForecastENOVEnovis3.754 of 5 stars$30.19+0.7%$51.00+68.9%-18.2%$1.71B$2.11B-2.127,367News CoverageAnalyst ForecastCDRECadre2.1731 of 5 stars$36.06-0.8%$31.50-12.6%-1.3%$1.48B$567.56M38.362,284News CoverageAnalyst ForecastNVCRNovoCure4.1445 of 5 stars$12.92+0.2%$28.79+122.8%-2.1%$1.44B$605.22M-8.281,488Positive NewsAnalyst ForecastCNMDCONMED4.6281 of 5 stars$45.64-0.8%$59.80+31.0%-27.2%$1.42B$1.31B12.933,900Analyst Forecast Related Companies and Tools Related Companies Inspire Medical Systems Competitors National Vision Competitors PROCEPT BioRobotics Competitors Artivion Competitors LeMaitre Vascular Competitors Liquidia Technologies Competitors Enovis Competitors Cadre Competitors NovoCure Competitors CONMED Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SIBN) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SiBone Please log in to your account or sign up in order to add this asset to your watchlist. Share SiBone With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
